Results 21 to 30 of about 2,460,082 (213)

Chronic Inflammatory Polyneuropathy

open access: yesPediatric Neurology Briefs, 2007
Thirteen children with chronic inflammatory demyelinating polyneuropathy monitored between 1975 and 2005 are reported from Centre hospitalier universitaire Sainte-Justine, Montreal, Canada.
J Gordon Millichap
doaj   +2 more sources

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

open access: yesBiologics: Targets & Therapy, 2010
Mohamed Mahdi-Rogers, Yusuf A RajaballyNeuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UKAbstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired heterogeneous disorder of immune ...
Mohamed Mahdi-Rogers, Yusuf A Rajabally
doaj   +1 more source

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy [PDF]

open access: yesBlood Cancer Journal
Ciltacabtagene-autoleucel (cilta-cel) is a CAR-T cell therapy highly active in relapsed/refractory multiple myeloma but can induce severe immune-mediated toxicities. We describe two patients who developed chronic inflammatory demyelinating polyneuropathy
M. Korenkov   +18 more
doaj   +2 more sources

Chronic inflammatory demyelinating polyneuropathy [PDF]

open access: yesJournal of the Neurological Sciences, 2013
Chronic inflammatory demyelinating polyneuropathy (CIDP) is the commonest treatable neuropathy in the western world. Untreated it may result in severe disability but if diagnosed and treated early there is effective treatment for the majority of patients.
Emily K, Mathey, John D, Pollard
  +11 more sources

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy [PDF]

open access: yesAnnals of Clinical and Translational Neurology
Objective To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Lars Masanneck   +15 more
doaj   +2 more sources

Minimal chronic inflammatory demyelinating polyneuropathy

open access: yes, 1997
Chronic inflammatory demyelinating polyneuropathy (CIDP) is clinically heterogeneous and the spectrum of severity is not well defined. Three patients were referred for mild distal paresthesias lasting more than 2 months and one for lumbar pain.
Lugaresi A.   +4 more
core   +4 more sources

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology [PDF]

open access: yesRomanian Journal of Neurology, 2023
Introduction. Neurological manifestations secondary to Hymenoptera stings are rare. However, the literature describes cases of severe central and peripheral nervous system damage.
Cristina Gatcan   +4 more
doaj   +1 more source

Neurosarcoidosis camouflaging as partial miller: Fisher syndrome

open access: yesIndian Journal of Rheumatology, 2023
Neurological involvement in sarcoidosis has varied presentations. Peripheral neuropathy is one of them. Symmetrical axonal type sensory-motor polyneuropathy is the most common form; focal and multifocal neuropathy, polyradiculopathy, and vascular ...
B N Shiva Prasad   +3 more
doaj   +1 more source

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY [PDF]

open access: yes, 2021
Chronic inflammatory demyelinating polyneuropathy (CIDP) merupakan penyakit neuropati autoimun kronik. CIDP klasik ditandai dengan hilangnya persepsi sensorik dan kelemahan anggota gerak secara progresif dan disertai hilangnya refleks selama lebih dari 8
Attiya Istarini, Indra, Syarif
core   +3 more sources

Chronic Inflammatory Demyelinating Polyneuropathy [PDF]

open access: yesJournal of the Royal Army Medical Corps, 1994
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare neurological disease. Definitive therapy is not yet established. We report our use of intravenous Immunoglobulin (iv IgG) in two cases of CIDP and review the therapeutic options available. Intravenous IgG is a ubiquitous practical treatment particularly in patients who do not respond to
H, Smith, I, Salam, L J, Findley
openaire   +2 more sources

Home - About - Disclaimer - Privacy